Increased human T-lymphotropic virus type II proviral load following highly active retroviral therapy in HIV-coinfected patients
- PMID: 12902815
- DOI: 10.1097/00126334-200308150-00019
Increased human T-lymphotropic virus type II proviral load following highly active retroviral therapy in HIV-coinfected patients
Publication types
MeSH terms
Substances
Grants and funding
- N01-HB-571115/HB/NHLBI NIH HHS/United States
- N01-HB-57116/HB/NHLBI NIH HHS/United States
- N01-HB-57117/HB/NHLBI NIH HHS/United States
- N01-HB-57118/HB/NHLBI NIH HHS/United States
- N01-HB-57119/HB/NHLBI NIH HHS/United States
- N01-HB-57120/HB/NHLBI NIH HHS/United States
- N01-HB-57121/HB/NHLBI NIH HHS/United States
- N01-HB-57122/HB/NHLBI NIH HHS/United States
- N01-HB-57123/HB/NHLBI NIH HHS/United States
- N01-HB-57124/HB/NHLBI NIH HHS/United States
- N01-HB-57125/HB/NHLBI NIH HHS/United States
- N01-HB-57126/HB/NHLBI NIH HHS/United States
- N01-HB-57127/HB/NHLBI NIH HHS/United States
- P30-MH59037/MH/NIMH NIH HHS/United States
- R01-HL62235/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
